China Uses Old To Fight New As Repurposed Drugs Take Coronavirus Role
Antimalarial Among Those Added To Guidelines
Executive Summary
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
You may also be interested in...
Case Grows For Bayer's Old Anti-Malarial To Treat COVID-19
Bayer's anti-malaria therapy chloroquine is being touted as a cheap, safe and effective drug for coronavirus. However the company's product is only made in Pakistan and a variety of import and export agreements need to be in place for other countries to get hold of it.
Fewer Wuhan Patients For Gilead Remdesivir Study: WHO
In a shocking and revealing account, a primary investigator of the front-runner antiviral drug for the coronavirus in China expresses concerns over finding enough patients for the study Wuhan, the outbreak's epicenter.
India Acts To Limit Supply Disruption From Coronavirus
Indian pharmaceutical companies will soon be asked to seek a no objection certificate for the export of 12 APIs and their formulations, as the country deals with Chinese raw material supply disruptions on the back of the coronavirus crisis. However, the move is not expected to impact the export quantum for now.